The 2022 ASCO Annual Meeting brings together colleagues from across the world with different disciplines and subspecialties related to cancer care. The meeting will have a hybrid format with both in-person and online attendance, featuring 200+ sessions that will compliment this year’s program theme: Advancing Equitable Cancer Care Through Innovation.

Whether you are attending the meeting in Chicago or online, you can join more than 85 livestream sessions from anywhere; discover 2,500+ poster presentations; take notes and download session slides; and participate in live Q&A and sessions with polling.

Taylor & Francis is a STM publisher, offering innovative publishing options and services that fit the evolving needs of authors and researchers worldwide. We connect you with the latest oncology research contributing to advancements in etiology, prevention, treatment and care, and diagnosis of cancer. Explore our oncology journal portfolio below and discover where you and your research belong next.  This year we also publish a number of new editions of flagship titles in Gynecologic Oncology (such as Robert Bristow’s Surgery for Ovarian Cancer, 4th edition) and Hematologic Oncology (such as Wojciech Gorczyca’s Flow Cytometry in Neoplastic Hematology, 4th edition).

<p><strong><a style="color:#ffffff;" href="https://authorservices.taylorandfrancis.com/publishing-open-access/oa-benefits/?utm_source=TaylorandFrancis&utm_medium=cms&utm_campaign=JRF28890">Open Access for Cancer Research</a></strong></p>

<p>Open access publishing makes academic articles permanently available online. Anyone, anywhere can read and build upon your research, increasing the reach and impact of your published work.</p>

<p>You can choose to publish open access in a fully OA journal or in an Open Select journal, known as hybrid publishing. We offer a variety of publishing models and licenses for you to choose across our journal portfolio from Taylor & Francis and Dove Medical Press, and publishing platform, F1000Research.</p>

<p>Open access is great for readers because it gives them immediate access to the latest research, but there are also many advantages to you, the author. Click the link below to learn more about the benefits of publishing open access.<p>

<p><a style="color:#ffffff;" href="https://authorservices.taylorandfrancis.com/publishing-open-access/oa-benefits/?utm_source=TaylorandFrancis&utm_medium=cms&utm_campaign=JRF28890">Learn More</a></p>

Open Access for Cancer Research

Open access publishing makes academic articles permanently available online. Anyone, anywhere can read and build upon your research, increasing the reach and impact of your published work.

You can choose to publish open access in a fully OA journal or in an Open Select journal, known as hybrid publishing. We offer a variety of publishing models and licenses for you to choose across our journal portfolio from Taylor & Francis and Dove Medical Press, and publishing platform, F1000Research.

Open access is great for readers because it gives them immediate access to the latest research, but there are also many advantages to you, the author. Click the link below to learn more about the benefits of publishing open access.

Learn More

 

Top Downloaded Articles


 


 


 

Related Resources




 

Related Books

Flow Cytometry in Neoplastic Hematology
Flow Cytometry in Neoplastic Hematology

Morphologic-Immunophenotypic-Genetic Correlation

Essentials of Cancer Survivorship
Essentials of Cancer Survivorship

A Guide for Medical Professionals